semaglutide · injectable
Zephira™
15–20% body weight reduction
Once-weekly injection proven to help people lose 15–20% of body weight in clinical trials.
- Once-weekly dosing
- Pre-filled for easy self-injection
- Clinically proven results
AdminZuri Health · Caribbean
Welcome to 💚 Zuri Health
Discover Zephira™ and Zuritide™ — the next generation of GLP‑1 therapies for diabetes and weight management, now available in the Caribbean.
Our products
Two breakthrough GLP‑1 treatments, now available.
Learn the science, the dosing, and the patient experience behind Zephira™ and Zuritide™ — and tell us which products you'd like to order.
tirzepatide · injectable
Zuritide™
Up to 22.5% body weight reduction
Dual-action GLP-1 for enhanced weight loss results. Up to 22.5% body weight reduction in clinical trials.
- Dual mechanism of action
- Enhanced efficacy
- Weekly dosing
Background & education
Why these therapies matter for doctors, pharmacists and dietitians.
GLP‑1 (Glucagon‑Like Peptide‑1) receptor agonists mimic the natural gut hormone released in response to food. They have become the leading specialised metabolic therapy for clinical weight management and conditions such as Type 2 diabetes and obesity, and your patients are already asking about them.
Built for clinicians
Designed for doctors, pharmacists and dietitians who advise patients on metabolic care, so you get the clinical detail your patients will ask about.
Evidence, not marketing
A grounded look at the mechanism, the trial data and the real-world protocols behind GLP‑1 and dual-action therapies.
Safety & contraindications
Clear guidance on MTC/MEN 2 contraindications, monitoring and the cold-chain handling these biologics demand.
How it works
Three mechanisms, one coordinated effect on appetite and glycaemia.
01
Glucose‑dependent insulin secretion
GLP‑1 receptor agonists enhance insulin release only when blood glucose is elevated, lowering hypoglycaemia risk.
02
Glucagon suppression
They suppress glucagon, the hormone that drives hepatic glucose output and raises blood sugar.
03
Delayed gastric emptying
Food stays in the stomach longer, so patients feel fuller sooner, eat less, and report fewer cravings.
Combined with diet and exercise, GLP‑1 therapies are clinically proven to induce sustainable body weight reductions of 15–20%. Next-generation dual-action agonists targeting both GLP‑1 and GIP receptors can facilitate weight loss of up to 22.5%.
The Zuri Health formulary
Three therapies, prescribed under physician oversight.
Zephira™
semaglutide
15–20%
Once-weekly single-action GLP‑1 agonist. Sustainable body weight reduction of 15–20% in controlled trials and within Zuri Health's own protocols.
Zuritide™
tirzepatide
Up to 22.5%
Next-generation dual-action agonist targeting both GLP‑1 and GIP receptors, currently the most effective non‑surgical weight loss treatment available.
Zelvanta™
semaglutide
Cardio benefits
Another frequently prescribed GLP‑1 option offering sustainable weight loss alongside proven cardiovascular benefits.
Guaranteed lowest price
Guaranteed cheapest cost in the region on every order placed through Zuri Health.
Cold-chain handling
Both semaglutide and tirzepatide are temperature-sensitive biologics requiring vaccine-grade cold-chain storage to remain effective from dispensary to patient.
Safety & clinical oversight
Potent therapies require careful patient selection.
GLP‑1 medications carry a warning for the potential risk of thyroid C‑cell tumors. They are strictly contraindicated in patients with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Zuri Health's program requires an initial online health history review and ongoing monitoring by a board-certified physician before any prescription is issued.
All medications dispensed through Zuri Health, including Zephira™, Zelvanta™ and Zuritide™, are FDA-approved or clinically validated, with every prescription reviewed by a board-certified provider against the patient's full medical history.
Patient story
“I've lost 45 pounds in 6 months with Zuri Health. The entire process was so easy, and my provider has been incredibly supportive throughout my journey.”
Sarah M.
Verified patient
−45 lbs
in 6 months
Key takeaways
A quick recap of where Zuri Health stands today.
Thank you for the open and engaged conversation. Here's a short review of the key points before you share your interest below.
The drugs
The products being distributed include the FDA‑approved formulation, produced and rebranded in South Florida for distribution in our region.
The cost
We're starting with an introductory offer at USD $100–$150 per vial. Price may vary depending on volume. Each vial is a month's supply, administered once per week.
Clinical guidelines
As we form a network of providers, we will run meetings, discussions and CMEs to produce guidelines on usage and continue meaningful engagement in the field.
When?!
Soon. We're moving quickly and will keep our provider network the first to know as orders open.
What else is coming
We're starting with these two flagship products and will expand to a wider range of products for safe usage on a phased basis.
Interest & orders
Tell us what you'd like to order.
Share your feedback and let us know which products you'd like to order or learn more about.